Researchers have identified a new biomarker in multiple sclerosis (MS): the thickness of the inflammatory rim surrounding ...

TLX101-CDx is an investigational positron emission tomography agent that targets the membrane transport proteins, LAT1 and LAT2.

Researchers at the University of Turku, Finland, have discovered a new biomarker that can predict the progression of multiple ...

A report from the Alzheimer’s Association says new treatments and blood tests could change how doctors detect and treat the ...

Mr Haynes was recovering from surgery to treat his tumour when his dog Taz began to suffer seizures. Taz deteriorated quickly ...

In a comprehensive Genomic Press perspective article published today, researchers from Fudan University and Shanghai ...

The solid cash conversion allows Telix to internally fund organic growth and flexibility to pursue acquisitions. We expect the company to reinvest the majority of earnings into R&D. We forecast ...

A research team at National Sun Yat-sen University has developed a non-invasive imaging technology designed for diagnosing ...

New findings from the FACEHBI study show that baseline amyloid PET scans in people with subjective cognitive decline can ...

Conference after conference, Roche scientists running the ongoing Brain Shuttle AD trial of trontinemab are dispensing ...